New Medicare AI Leaves Neurotech In Denial

Despite its growing “deeptech” bonafides, the US neurotechnology industry has wound up on the wrong side of AI.

The Centers for Medicare and Medicaid Services (CMS) announced a new pilot program to test whether AI-enabled claim denials will save money. How? By automatically reducing the use of implanted neurostimulation and other service categories “that may be fraudulent, and wasteful, or of low-value and medically unnecessary.”

The Wasteful and Inappropriate Service Reduction (